Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

LivaNova erhält 510(k)-Freigabe der US-amerikanischen FDA für Essenz-Herz-Lungen-Maschine für kardiopulmonale Bypassverfahren
LivaNova erhält 510(k)-Freigabe der US-amerikanischen FDA für Essenz-Herz-Lungen-Maschine für kardiopulmonale Bypassverfahren


LivaNova PLC (Nasdaq: LIVN), ein marktführendes Unternehmen im Bereich medizintechnische Innovationen, gab heute bekannt, dass es die 510(k)-Freigabe von der US-amerikanischen Food and Drug

LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™

EQS-Adhoc: STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023
EQS-Adhoc: STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023
EQS-Adhoc: STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023
EQS-News: Drägerwerk AG & Co. KGaA: Dräger expects return to profitable growth in 2023
EQS-News: Drägerwerk AG & Co. KGaA: Dräger expects return to profitable growth in 2023
EQS-News: Drägerwerk AG & Co. KGaA: Dräger expects return to profitable growth in 2023
AEVIS VICTORIA SA – AEVIS VICTORIA achieved consolidated revenues of CHF 1.143bn in 2022, up 27.8% (CHF 895.0m) from prior year.
AEVIS VICTORIA SA – AEVIS VICTORIA achieved consolidated revenues of CHF 1.143bn in 2022, up 27.8% (CHF 895.0m) from prior year.
AEVIS VICTORIA SA – AEVIS VICTORIA achieved consolidated revenues of CHF 1.143bn in 2022, up 27.8% (CHF 895.0m) from prior year.
Acadia Healthcare Breaks Ground on New Behavioral Health Hospital in Arizona
Acadia Healthcare Breaks Ground on New Behavioral Health Hospital in Arizona


Acadia Healthcare Company today held a groundbreaking ceremony marking the beginning of construction on the new hospital that the company is building to serve residents of Mesa, Arizona, and

EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft)
EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft)
EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft)
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick


Leaders from Agilent Technologies Inc. (NYSE: A) today joined Colorado Governor Jared Polis and local government officials to break ground on Agilent’s $725 million investment to double

EQS-News: SARTORIUS AG: The Supervisory Board of Sartorius AG proposes  a dividend of 1.44 euros per preference share
EQS-News: SARTORIUS AG: The Supervisory Board of Sartorius AG proposes a dividend of 1.44 euros per preference share
EQS-News: SARTORIUS AG: The Supervisory Board of Sartorius AG proposes a dividend of 1.44 euros per preference share
EQS-News: Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high
EQS-News: Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high
EQS-News: Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation
EQS-Adhoc: GN Store Nord A/S: GN Store Nord announces intention to initiate a rights issue
EQS-Adhoc: GN Store Nord A/S: GN Store Nord announces intention to initiate a rights issue
EQS-Adhoc: GN Store Nord A/S: GN Store Nord announces intention to initiate a rights issue
LivaNova leitet die begrenzte Markteinführung des Essenz Perfusion System für kardiopulmonale Bypassverfahren in Europa ein
LivaNova leitet die begrenzte Markteinführung des Essenz Perfusion System für kardiopulmonale Bypassverfahren in Europa ein


LivaNova PLC (Nasdaq: LIVN), ein marktführendes Unternehmen im Bereich Medizintechnik und Innovation, hat heute den Beginn einer begrenzten kommerziellen Freigabe für das Essenz™ Perfusion System*

LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures
LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion System*. The release has

Bronson Healthcare and Acadia Healthcare Name Deb Rozewicz As CEO of Bronson Behavioral Health Hospital
Bronson Healthcare and Acadia Healthcare Name Deb Rozewicz As CEO of Bronson Behavioral Health Hospital


Bronson Healthcare and Acadia Healthcare Company have named Deb Rozewicz, RN, as chief executive officer for Bronson Behavioral Health Hospital, the 96-bed inpatient behavioral health hospital

Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System
Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today unveiled the company’s second Super Bowl commercial, which announces the US

LivaNova Launches SenTiva DUO
LivaNova Launches SenTiva DUO


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today launched SenTiva DUO™, an implantable pulse generator (IPG) with a dual-pin header to provide VNS

EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: EBITDA for 2022 above the forecast range on the basis of preliminary figures
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: EBITDA for 2022 above the forecast range on the basis of preliminary figures
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: EBITDA for 2022 above the forecast range on the basis of preliminary figures
EQS-Adhoc: GN Store Nord A/S: GN Store Nord announces changes to the Board of Directors
EQS-Adhoc: GN Store Nord A/S: GN Store Nord announces changes to the Board of Directors
EQS-Adhoc: GN Store Nord A/S: GN Store Nord announces changes to the Board of Directors
New waters_connect System Monitoring Software Maximizes Productivity with Real-Time, Cloud-Native Lab Management
New waters_connect System Monitoring Software Maximizes Productivity with Real-Time, Cloud-Native Lab Management


Waters Corporation (NYSE:WAT) today announced waters_connect™ System Monitoring, a new Software-as-a-Service (SaaS) application that enables laboratory managers and analysts to monitor the

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2022: net sales and earnings significantly below prior year despite continued high order backlog – forecast 2023: return to growth and profitability
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2022: net sales and earnings significantly below prior year despite continued high order backlog – forecast 2023: return to growth and profitability
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2022: net sales and earnings significantly below prior year despite continued high order backlog – forecast 2023: return to growth and profitability
Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program
Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program


Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), is pleased to announce that coverage for Dexcom G6 rtCGM System on the Non-Insured Health Benefits

Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses
Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses, today announced a partnership with actress and beauty entrepreneur, Peyton List, to